Articles with the topic: featured

Interview: CHDI Management

Interview: CHDI Management

HDBuzz interviews three top scientists from CHDI, the biggest funder and driver of HD research worldwide

Dr Jeff CarrollFebruary 25, 2011

CHDI Report: Day 3

CHDI Report: Day 3

Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies

Dr Jeff CarrollFebruary 10, 2011

CHDI Report: Day 2

CHDI Report: Day 2

Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD

Dr Ed WildFebruary 09, 2011

CHDI Report: Day 1

CHDI Report: Day 1

Day 1 of CHDI’s HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene

Dr Jeff CarrollFebruary 08, 2011

Welcome to HDBuzz

Welcome to HDBuzz

Welcome to HDBuzz. Huntington’s disease research news. In plain language. Written by scientists. For the global HD co

Dr Ed WildJanuary 18, 2011

Is Huntington’s disease twice as common as we thought?

Is Huntington’s disease twice as common as we thought?

New data suggest there may be twice as many people with HD symptoms as previously thought – and even more at risk

Dr Ed WildNovember 27, 2010

Two large HD observational studies – COHORT and Registry – merge to create ENROLL-HD

Two large HD observational studies – COHORT and Registry – merge to create ENROLL-HD

Merger of two major Huntington’s Disease observational trials creates ENROLL-HD

Dr Jeff CarrollNovember 24, 2010

Huntexil for symptoms of Huntington's disease: where are we now?

Huntexil for symptoms of Huntington's disease: where are we now?

Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex

Dr Ed WildNovember 16, 2010

Minocycline: the end of the road?

Minocycline: the end of the road?

DOMINO clinical trial result: minocycline doesn’t slow down HD and shouldn’t be studied in larger trials.

Dr Ed WildNovember 10, 2010